STOCK TITAN

Freddie MAC 5% PFD (FMCKK) Financials

FMCKK OTC
FY2025 annual
Revenue $23.3B -2.7% YoY
Net Income Not reported for FY2025
EPS (Diluted) -$0.02 n/m YoY
Operating Cash Flow $19.4B +192.3% YoY
Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Sep 30, 2026 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q3 FY2026, filed Oct 29, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the FMCKK SEC filings page.

Freddie MAC 5% PFD (FMCKK) reported $23.3B in revenue for fiscal year 2025, down 2.7% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI FMCKK FY2025

The balance sheet is liability-dominated, while reported long-term debt shrank without making the institution lightly financed.

The debt reshuffling was substantial: long-term debt fell 94.8% from FY2023 to FY2024, yet liabilities still represented 98.2% of assets in FY2024. In FY2025, liabilities remained 98.0% of assets while liabilities-to-equity was 48.7x, suggesting the shift changed liability composition more than overall leverage.

This is an asset-heavy financial model: FY2024 net income of $11.9B produced only 0.4% return on assets against a $3.4T asset base, so balance-sheet scale matters more than ordinary operating margins.

Cash generation decoupled from sales: operating cash flow rose from $6.6B in FY2024 to $19.4B in FY2025 even as revenue declined, indicating reported cash movement was not simply tracking top-line growth. In FY2024, operating cash flow equaled 55.9% of net income, so accounting earnings did not fully arrive as operating cash.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Financial health score not available

We do not publish a peer-relative financial health score for Freddie MAC 5% PFD, because the score only covers companies whose filings and listing give us what it needs to compare them with their peers. The metrics below are current.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$6.8B
YoY+18.7%
QoQ+13.7%

Freddie MAC 5% PFD generated $6.8B in revenue in Q3 2026. This represents an increase of 18.7% from the same quarter a year earlier. Against the prior quarter it is up 13.7%.

Net Income
$3.2B
YoY+16.7%
QoQ-15.7%

Freddie MAC 5% PFD reported $3.2B in net income in Q3 2026. This represents an increase of 16.7% from the same quarter a year earlier. Against the prior quarter it is down 15.7%.

EPS (Diluted)
$0.01
YoYn/m
QoQn/m

Freddie MAC 5% PFD earned $0.01 per diluted share (EPS) in Q3 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

EBITDA

Not reported for Q3 2026.

Cash & Balance Sheet

Cash & Debt
$4.6B
YoY-1.4%
QoQ+5.6%

Freddie MAC 5% PFD held $4.6B in cash against $157.0B in long-term debt as of Q3 2026.

Shares Outstanding
650M
YoY0.0%
QoQ0.0%

Freddie MAC 5% PFD had 650M shares outstanding in Q3 2026. That is unchanged from the same quarter a year earlier. It is unchanged from the prior quarter.

Free Cash Flow

Not reported for Q3 2026.

Dividends Per Share

Not reported for Q3 2026.

Margins & Returns

Net Margin
47.5%
YoY-0.8pp
QoQ-16.6pp

Freddie MAC 5% PFD's net profit margin was 47.5% in Q3 2026, showing the share of revenue converted to profit. This is down 0.8 percentage points from the same quarter a year earlier. Against the prior quarter it is down 16.6 percentage points.

Return on Equity
4.0%
YoY-0.1pp
QoQ-0.9pp

Freddie MAC 5% PFD's quarterly ROE was 4.0% in Q3 2026: one quarter's net income over shareholder equity, not annualized. This is down 0.1 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.9 percentage points.

Gross Margin

Not reported for Q3 2026.

Operating Margin

Not reported for Q3 2026.

Capital Allocation

None of these metrics is reported for Q3 2026.

FMCKK Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

FMCKK quarterly income statement
MetricQ3'2610-QQ2'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Revenue$6.8B+18.7%$6.0B+1.3%N/A$5.7B-1.7%$5.9B-1.2%N/A$6.3B+17.8%$5.8B+2.6%
SG&A Expenses$686.0M-4.2%$676.0M-9.6%N/A$716.0M+0.4%$748.0M+8.6%N/A$749.0M$713.0M
Interest Expense$29.2B+6.1%$28.3B+5.7%N/A$27.5B+10.9%$26.7B+10.8%N/A$25.6B+10.9%$24.8B+12.5%
Income Tax$781.0M+15.7%$936.0M+59.2%N/A$675.0M-8.9%$588.0M-15.4%N/A$796.0M+8.2%$741.0M+7.1%
Net Income$3.2B+16.7%$3.8B+60.8%N/A$2.8B-10.7%$2.4B-13.7%N/A$3.2B+10.6%$3.1B+15.6%
EPS (Basic)$0.01n/m$0.00n/m$0.00-100.0%$0.00n/m-$0.01n/mN/A$0.01n/m-$0.02n/m
EPS (Diluted)$0.01n/m$0.00n/m$0.00-100.0%$0.00n/m-$0.01n/mN/A$0.01n/m-$0.02n/m
Diluted Shares (Avg)3.23B0.0%3.23B0.0%N/A3.23B0.0%3.23B0.0%N/AN/A3.23B0.0%

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, Operating Income, EBITDA.

FMCKK Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

FMCKK quarterly balance sheet
MetricQ3'2610-QQ2'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Total Assets$3.5T+1.8%$3.5T+2.4%$3.5T+3.3%$3.5T+3.8%$3.4T+3.9%$3.4T+3.7%$3.4T+3.2%$3.3T+2.2%
Cash & Equivalents$4.6B-1.4%$4.3B+1.3%$5.3B-3.7%$4.6B-4.8%$4.3B-22.9%N/A$5.5B-8.1%$4.9B-9.3%
Total Liabilities$3.5T+1.5%$3.4T+2.0%$3.4T+3.0%$3.4T+3.5%$3.4T+3.6%$3.3T+3.4%$3.3T+2.9%$3.3T+1.8%
Long-Term Debt$157.0B$163.7B$169.3B+1.2%N/AN/AN/A$167.3B-94.8%$3.3T+1.7%
Total Equity$81.0B+19.8%$77.8B+20.0%$70.4B+18.1%$67.6B+19.9%$64.8B+21.8%$62.4B+23.7%$59.6B+24.8%$56.4B+26.3%
Retained Earnings-$1.9Bn/m-$5.1Bn/m-$12.5Bn/m-$15.3Bn/m-$18.1Bn/m-$20.5Bn/m-$23.3Bn/m-$26.5Bn/m

Not reported in any period shown, so not listed: Current Assets, Short-Term Investments, Inventory, Accounts Receivable, Long-Term Investments, Goodwill, Current Liabilities, Non-Current Liabilities.

FMCKK Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

FMCKK quarterly cash flow statement
MetricQ3'2610-QQ2'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Operating Cash Flow$4.2B-16.9%N/A$2.6Bn/m$5.1B+37.1%N/AN/A-$900.0M-147.8%$3.7B+410.5%
Investing Cash Flow$17.0Bn/mN/A$4.7Bn/m-$881.0M-200.7%N/AN/A-$13.6B-181.8%$875.0M-96.1%
Financing Cash Flow-$21.0Bn/mN/A-$6.6B-143.5%-$3.8Bn/mN/AN/A$15.2Bn/m-$5.3Bn/m

Not reported in any period shown, so not listed: Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Dividends Paid, Share Buybacks.

FMCKK Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

FMCKK quarterly financial ratios
MetricQ3'2610-QQ2'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Net Margin47.5%-0.8pp64.1%+23.7ppN/A48.3%-4.9pp40.4%-5.8ppN/A50.9%-3.3pp53.2%+6.0pp
Return on Equity4.0%-0.1pp4.9%+1.3ppN/A4.1%-1.4pp3.7%-1.5ppN/A5.4%-0.7pp5.5%-0.5pp
Return on Assets0.1%0.0pp0.1%0.0ppN/A0.1%0.0pp0.1%0.0ppN/A0.1%0.0pp0.1%0.0pp
Debt-to-Equity1.942.112.41-0.4xN/AN/AN/A2.81-64.3x57.66-13.9x
Liabilities-to-Equity42.62-7.7x44.24-7.8x48.69-7.2x50.30-8.0x52.02-9.1x53.63-10.5x55.85-11.9x58.28-14.0x
Asset Turnover0.000.0x0.000.0xN/A0.000.0x0.000.0xN/A0.000.0x0.000.0x

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Current Ratio, FCF Margin.

Frequently Asked Questions

Freddie MAC 5% PFD (FMCKK) reported $23.3B in total revenue for fiscal year 2025. This represents a -2.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Freddie MAC 5% PFD (FMCKK) revenue declined by 2.7% year-over-year, from $23.9B to $23.3B in fiscal year 2025.

Freddie MAC 5% PFD (FMCKK) reported diluted earnings per share of -$0.02 for fiscal year 2025. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

As of fiscal year 2025, Freddie MAC 5% PFD (FMCKK) had $5.3B in cash and equivalents against $169.3B in long-term debt.

Freddie MAC 5% PFD (FMCKK) generated $19.4B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Freddie MAC 5% PFD (FMCKK) had $3.5T in total assets as of fiscal year 2025, including both current and long-term assets.

Freddie MAC 5% PFD (FMCKK) had 650M shares outstanding as of fiscal year 2025.

Freddie MAC 5% PFD (FMCKK) had a debt-to-equity ratio of 2.41 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.

Freddie MAC 5% PFD (FMCKK) had a liabilities-to-equity ratio of 48.69 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.

Back to top